RSCM
IGMS

Rock Springs Capital Management’s IGM Biosciences IGMS Stock Holding History

Rock Springs Capital Management’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-19,762
Closed -$1.46M – 160
2020
Q3 		$1.46M Sell
19,762
-75,516
-79% -$4.47M 0.04% 140
2020
Q2 		$6.96M Buy
+95,278
New +$5.79M 0.19% 117

Other funds holding IGMS

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Rock Springs Capital Management's IGMS Position: Q4 2020 in Review

Rock Springs Capital Management sold out of IGM Biosciences (IGMS) in Q4 2020, closing a stake of 19,762 shares — an estimated $1.46M sold.

Rock Springs Capital Management first reported a position in IGMS in Q2 2020 and held it in 2 quarters. The position peaked at $6.96M in Q2 2020. 107 funds tracked by Wall St. Rank hold IGMS as of Q4 2020.

  • Rock Springs Capital Management reported no remaining IGM Biosciences position as of Q4 2020 after selling out during the quarter.
  • Rock Springs Capital Management sold 19,762 IGM Biosciences shares in Q4 2020, an estimated $1.46M.
  • Rock Springs Capital Management first reported a position in IGM Biosciences in Q2 2020 and held it in 2 quarters.
  • Rock Springs Capital Management's IGM Biosciences position peaked at $6.96M in Q2 2020.
  • 107 funds tracked by Wall St. Rank held IGM Biosciences as of Q4 2020.

Based on Rock Springs Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.